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Malaria is caused by Plasmodium sp. parasites transmitted by infected female Anopheles sp. 
mosquitoes. The survival of the parasites in the host relies on detoxifying free heme by 
biocrystallization into insoluble crystals called hemozoin. This mechanism of self-preservation 
is targeted by a certain class of antimalarial drugs, which are screened and selected based on 
their capacity to inhibit the formation of hemozoin crystals. Therefore, experimental techniques 
capable of characterizing accurately the kinetics of crystal formation are valuable. Relying on 
the optical anisotropy of hemozoin, we describe the kinetics of β-hematin crystal formation 
through the statistical analysis of photon counts of dynamic depolarized light scattering 
(DDLS), in the absence and presence of an antimalarial drug (chloroquine, CQ). We find that 
CQ has an impact on both the nucleation and growth of the crystals. 
 
Malaria is a deadly infective disease[1] of the blood that is caused by Plasmodium sp. parasites, 
which are transmitted from person to person by infected female Anopheles sp. mosquitoes. 
Inside red blood cells, the parasite degrades and digests hemoglobin to supply its own 
metabolism.[2,3] During this process, the parasite releases a non-digested molecule: heme.  
Heme is highly toxic to the parasite and disrupts the function of its cell membrane, which would 
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result in cell lysis and ultimately self-digestion.[4] To prevent this, the parasite neutralizes heme 
by biocrystallization: the oxidation and dimerization of heme is followed by a well-defined self-
assembly through hydrogen bonding and π-stacking into a triclinic crystal structure (Figure 
1).[5]  
 
Figure 1. The envisaged route of biocrystallization of heme through dimerization and self-
assembly into hemozoin. The heme molecule has a planar structure, and produces 
centrosymmetric μ-propionate dimers to generate the basic unit of hemozoin crystals. Then, 
hemozoin is formed by reciprocal hydrogen bonds between carboxylic acid groups, forming a 
supramolecular system that self-assembles by regular π-stacking. 
Given that hemozoin crystallization is an elementary mechanism in the detoxification of heme, 
a key concept defining the quinoline-sp. antimalarial drugs is the inhibition of hematin self-
assembly. While this approach has an acknowledged history in antimalarial chemotherapy, drug 
resistance has reemerged and has become responsible for the increase in malaria-related 
mortality, in particular in Africa.[6,7] Drug discovery necessitates high-throughput assays[8] of 
new compounds and a profound understanding of the mechanism and kinetics of crystallization 
and its inhibition.[5,9,10] The availability of synthetic hemozoin—β-hematin, whose physical 
properties, including structural optical and magnetic properties, are identical to hemozoin 
isolated from the parasite[11]—has accelerated the investigations.[12] Here we show that dynamic 
depolarized light scattering (also known as depolarized dynamic light scattering, DDLS) 
presents an outstanding potential in addressing hemozoin crystallization. The applicability of 
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DDLS is granted by the self-assembly of heme and hemozoin, that is, self-assembly is strictly 
orientation-specific and ensures that anisotropy is a long-range feature being several orders of 
magnitude beyond the size of the molecule. The hemozoin crystals present an elongated needle 
or brick-like (parallelepiped) morphology, which means, that the optical refractive index, and 
thus, polarizability is different along the directions defined by π-stacking and hydrogen 
bonding, respectively. Accordingly, the elements of the polarizability tensor are not identical. 
Due to this anisotropy in the polarizability, the polarization vector of the scattered light is not 
equal to the polarization vector of the laser light illuminating the hemozoin crystal, and the 
scattered light contains a ‘depolarized’ component (𝑣ℎ) perpendicular to the original 
polarization (𝑣𝑣) of the laser. Therefore, upon translational and rotational diffusion, the 
amplitude of depolarized scattering will fluctuate, and the rate and amplitude of the fluctuation 
of the scattering intensity will carry information about Brownian dynamics and particle size. It 
has been shown before that the statistical analysis of the photon count distribution of the 
scattered light describes accurately Brownian dynamics.[13,14] Therefore, we used this technique 
to follow the self-assembly and growth of β-hematin crystals in the absence and presence of 
CQ. The distribution of photon counts (𝑛) of depolarized dynamic light scattering is[15] 
(1) 𝑃(𝑛) = (𝑛+𝑀−1
𝑀−1
) ∙ (
𝑀
〈n〉+𝑀
)
𝑀
∙ (
〈n〉
〈n〉+𝑀
)
𝑛
 . 
〈𝑛〉 is linearly proportional to the mean intensity of depolarized scattering (𝐼𝑣ℎ) and 𝑀 is a 
function of the Brownian dynamics of the particle (𝛤) and the time interval used to count the 
photons (𝜏):  
(2) 𝑀(𝛤, 𝜏) =
2∙(𝛤∙𝜏)2
ⅇ−2∙𝛤∙𝜏+2∙𝛤∙𝜏−1
. 
The Brownian dynamics of the particle is described by its rotational (𝐷𝑅) and translational (𝐷𝑇) 
diffusivity[16] 
(3) 𝛤 = 6 ∙ 𝐷𝑅 + 𝑞
2 ∙ 𝐷𝑇 
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where 𝑞 = 4𝜋/𝜆 𝑛𝑠 𝑠𝑖𝑛(𝜃/2) is the momentum transfer, with 𝜃 being the scattering angle, 𝜆 
the wavelength of the scattered waves and 𝑛𝑠 the refractive index of the solution.
[16] Using the 
concept of hydrodynamic radius—defined as the radius of a sphere with an equivalent 
diffusivity—we can determine the hydrodynamic radius of the β-hematin crystal  
(4)  𝐷𝑅 =
 𝑘𝐵𝑇
8 𝜋 
1
𝑅3
 
(5) 𝐷𝑇 = 
 𝑘𝐵𝑇
6 𝜋 
1
𝑅
  
where 𝑅 is the hydrodynamic radius, 𝑘𝐵 the Boltzmann constant, 𝑇 the temperature,  the 
viscosity of the solution. Starting from Equation 1, it can be shown that there is a fundamental 
relationship between 𝑀, the variance and mean of the photon count distribution: 
(6) 〈𝑛2〉 − 〈𝑛〉2 = 〈𝑛〉 +
〈𝑛〉2
𝑀
 
where 
(7) 〈𝑛𝑓〉 ≡ ∑ 𝑛𝑓 ∙ 𝑃(𝑛)∞𝑛=0 . 
The essence of Equation 1-7 is that the mean and variance of the photon count distribution of 
the fluctuations of the depolarized component of the scattered light describes quantitatively 
Brownian dynamics, and therefore, based on the optical anisotropy of β-hematin, the mean and 
variance of 𝑃(𝑛) is expected to be dependent on 𝑞2. To test this, we recorded depolarized 
scattering of a dilute suspension of β-hematin, and analyzed 𝑃(𝑛) at several angles (15°, 
20°…45°, Experimental Section). We used a laser wavelength of 𝜆 = 660 nm, where light 
absorption of hemozoin and β-hematin is low (Figure 2a). Figure 2b shows the traces of photon 
counts recorded at a sampling rate of 19 Hz at the different angles. Both the mean and the 
amplitude of the fluctuations decreases with the angle of scattering. Figure 2c shows the 
corresponding photon count distributions, and Figure 2d shows the relaxation rate 𝛤—
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determined at each angle via Equation 1 and 7—which exhibits a linear dependence on 𝑞2. 
Therefore, β-hematin—and thus hemozoin—is indeed suitable for DDLS analysis. 
  
Figure 2. a) UV-Vis optical extinction spectrum of β-hematin suspended in water. To collect 
DDLS data, we used a laser wavelength of 𝜆 = 660 nm, where light absorption is low. b) 
Stream of photon counts recorded consecutively at different scattering angles. c) The 
corresponding photon count distributions. d) The 𝑞2-dependence of the Brownian dynamics of 
the β-hematin crystals, determined from the photon counts. The data points define a straight 
line with a nonzero intercept. The solid line is the best linear fit that determines a hydrodynamic 
radius of 𝑅𝐻 = 309 ± 10 nm (estimate ± standard error). 
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To follow the self-assembly depicted in Figure 1, β-hematin was dissolved in sodium h 
ydroxide, and the addition of acetic acid triggered the isothermal recrystallization 
(Experimental Section). In the first experiment, the self-assembly and recrystallization of β-
hematin was triggered alone, and in the second experiment, the recrystallization of β-hematin 
was triggered in the presence of CQ. TEM images—taken by isolating the β-hematin after 30 
minutes of recrystallization time—supported by Fourier-transform infrared spectroscopy (FT-
IR) and X-ray diffraction (XRD) show that self-assembly indeed resulted in crystallization 
(Figure 3), and consequently, depolarization is the outcome of light scattering from reassembled 
β-hematin. Figure 4 displays the primary steps of obtaining the necessary information from the 
photon counts to describe the formation of β-hematin crystals. Figure 4a shows the two 30-
minutes-long traces of photon counts recorded at a sampling rate of 19 Hz. A 30-second-long 
period of the second trace—divided into three 10-second-long parts—is shown in Figure 4b. 
The corresponding photon count distributions and first two raw moments of 𝑃(𝑛) are shown in 
Figure 4c and d, respectively. The full length of the photon count traces were analyzed via 
Equation 1-7 in terms of mean scattering intensity (𝐼𝑣ℎ = 〈𝑛〉) and relaxation rate (𝛤). Figure 
5a and b shows that 𝐼𝑣ℎ increases and  decreases with crystallization time. The crystallization 
of β-hematin in the presence of CQ is initially rapid but considerably slows down after 3-4 
minutes, and after 20 minutes, the crystallization practically levels off. The crystallization 
kinetics of β-hematin in the absence of CQ displays a quite different kinetic: the initial rate of 
crystallization is moderate but the crystals form and grow steadily. 
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Figure 3. a)-c) Two TEM micrographs of each β-hematin sample. The scale-bars mark 500 nm. 
d) FT-IR absorbance spectra. β-hematin crystals as received (𝛽, black), in dissolved non-
crystalline state (𝛽𝑑, gray) and recrystallized in the absence of CQ (𝛽𝑟, blue). The spectra are 
shifted vertically for the sake of clarity. Three maxima are attributed to the chemical bonds 
characteristic to β-hematin: the maxima at 1205 cm-1 and 1651 cm-1 correspond to the 
coordinated carboxylate C―O and C=O stretches, respectively, and the maximum at 1703 cm-
1 corresponds to the C=O stretch of the free carboxylic acid group.[10,17,18] Apart from the non-
crystalline heme, these maxima are clearly visible in the FT-IR patterns. e) XRD patterns of β-
hematin crystals as received (𝛽, black), in dissolved non-crystalline state (𝛽𝑑, gray) and 
recrystallized in the absence of CQ (𝛽𝑟, blue). The Miller indices describing the orientation of 
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parallel crystal planes characteristic to β-hematin are indicated.[19] The absence of Bragg peaks 
and corresponding crystal planes in the case of non-crystalline heme is evident. 
 
Figure 4. a) The traces of photon counts recorded during recrystallization of β-hematin in the 
presence of chloroquine (With CQ) and absence of chloroquine (Without CQ). b) A 30-second-
long period of the photon count trace in the presence of chloroquine divided into three equal 
parts. c) The corresponding photon count distributions, and d) their first two raw moments. 
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Figure 5. The crystallization kinetics of β-hematin in the presence of chloroquine (With CQ) 
and absence of chloroquine (Without CQ).  a) The natural logarithm of the mean scattering 
intensity as a function of crystallization time. b) The natural logarithm of the relaxation rate as 
a function of crystallization time. c) The natural logarithm of the hydrodynamic radius as a 
function of crystallization time. d) The natural logarithm of the relative number of β-hematin 
crystals: 𝑁 = 𝐶𝑤𝑖𝑡ℎ 𝐶𝑄/𝐶𝑤𝑜 𝐶𝑄, where 𝐶 denotes the concentration of the crystal nuclei formed 
in the absence and presence of CQ. For the sake of clarity, the data points on each panel present 
the average of five measurements, and the error bars present the standard errors.  
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To understand the meaning of these observations, we adopt the approximation of the Rayleigh-
Ganz-Debye (RGD) theory.[20] The mean intensity may be expressed as 𝐼𝑣ℎ ∝ 𝐶 ∙ 𝑉
2, where 𝐶 
is the concentration and 𝑉 is the volume of the β-hematin crystals. The volume of the particle 
is proportional to the hydrodynamic volume, which may be expressed by the hydrodynamic 
radius (𝑅, Figure 5c) as 𝑉 = 4/3 𝜋 ∙ 𝑅3, where 𝑅 is determined from  (Equation 3). The 
formation of the crystals results from nucleation and growth. First, small clusters form and lose 
and gain molecules until a specific critical size is reached (called: nucleus or seed), from where 
growth occurs. 𝑉 is proportional to the degree of growth, and the concentration of β-hematin 
(𝐶) is proportional to the concentration of the nuclei. Accordingly, the concentration of crystals 
may be expressed as 𝐶 ∝ 𝐼𝑣ℎ/𝑅
6. Thus, we estimate the ratio of the concentrations of β-hematin 
crystals grown in the presence of CQ and in the absence of CQ as 𝑁 = 𝐶𝑤𝑖𝑡ℎ 𝐶𝑄/𝐶𝑤𝑜 𝐶𝑄. Figure 
5c and d show that in the presence of CQ the number of nuclei is higher, but the crystals do not 
reach the same volume as in the absence of CQ. 
The latter is in complete agreement with the earlier picture that the drug-heme complex 
negatively affects crystal formation.[21] One the one hand, there is a well-supported and 
evidence-based consensus that the growth of β-hematin crystals follow a classical mechanism, 
in which the deposition of solute heme builds and spreads new crystal layers.[22,23] The 
deposition is monomolecular and follows a first-order chemical kinetics. In this classical 
process, a new layer is deposited onto the smooth surface of the previous layer, and its height 
is typically one lattice spacing.[24] The decreased rate of crystal growth in the presence of CQ 
is attributed to the adsorption and relatively strong binding of CQ to the facets of the crystal, 
which may arrest the classical buildup and spread of new crystal layers.[10,25,26] Our results 
indeed show that—as expected—crystal growth is hindered by the presence of CQ (Figure 5c). 
In the presence of CQ, the eventual hydrodynamic radius (close to 400 nm) is less than fourth 
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of the size measured in the absence of CQ (more than 1800 nm), where the crystals may grow 
as large as convenient in the given experimental environment. 
On the other hand, crystal growth and crystal birth (nucleation) are independent and 
concurrent processes, and therefore, there is an alternative hypothesis that explains the 
inhibition of crystallization by the formation of CQ-heme complexes.[27-29] This route of 
inhibition reduces the concentration of heme, and thus, directly affects the nucleation rate as 
well.[10] We observed in our system that more crystals—however, considerably smaller—are 
formed in the presence of CQ and grew faster (Figure 5c and d). This shows that CQ did not 
reduce the nucleation rate. To account for this evidence, we offer the following argument: 
nucleation requires a considerably smaller amount of molecules than the additional growth of 
an already existing crystal whose surface is increasing with volume. Therefore, if nucleation is 
not affected but crystal growth is hindered by the presence of CQ, the rate of nucleation will 
increase owing to the availability of the heme that is eventually not able to attach to the surface 
of the crystals. In the absence of CQ, the growth of a crystal is uninhibited, and thus, it can keep 
growing, which requires increasing heme equivalents, hence the rate of nucleation will decrease 
achieving a plateau in DDLS. 
To summarize, we believe that dynamic light scattering, DDLS in particular, could 
easily find its way to antimalarial studies addressing biocrystallization. We showed that DDLS 
is a straightforward assay in the context of quinoline-sp. antimalarial chemotherapy, where the 
inhibition of heme self-assembly and crystal growth is the primary target. While the parameters 
of hemozoin biocrystallization we studied here may be specific and not the only possible choice, 
the analysis is based on general physical and mathematical principles underlying the theory of 
light scattering. These principles ensure that the technique is suitable for any system exhibiting 
the physical features of self-assembly, completely independently of the parameters of the 
system, such as chemical reactions and concentrations. Additionally, the approach is 
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suitable[30,31] for miniaturization and integration into microfluidic platforms and lab-on-a-chip 
assays,[32] where automation and parallelization for high-throughput is desired.[13] Furthermore, 
unlike other techniques,[33] depolarized light scattering enables a cost-effective design,[13] and 
fiber-optics based detection probes small volumes on the order of nanoliters.[34]  
Experimental Section 
Synthetic hemozoin (β-hematin) was purchased from InvivoGen (San Diego, CA) and was used 
as received. Sodium hydroxide (≥ 98%), chloroquine diphosphate salt (≥98%) (CQ), and acetic 
acid (≥ 99.7%) were purchased from Sigma Aldrich. β-hematin was suspended in ultrapure 
water. Ultrapure water was obtained from a Purelab Flex II (Veolia water system) with a 
resistance of 18.2 mΩ, and an LC208 purification pack. The ultrapure water was filtered with 
a Nylon 66 syringe filter with a pore size of 0.22 μm (BGB Analytik, Switzerland). 0.10 mg 
(0.15 mmol) of β-hematin were weighed in a glass vial and were suspended in 3 mL of the 
filtered water. To a standard cell culture glass tube, 3 mL of the filtered water were introduced, 
and 200 μL of the β-hematin suspension were added yielding a suspension with a concentration 
of 2.22 μg mL-1 (3.44 nmol mL-1). The suspension was sonicated for three minutes in a sonicator 
bath (Sonoswiss SW3) to yield a homogeneous suspension of non-aggregated crystals. The 
crystallization of β-hematin was achieved by employing a described procedure.[35] Briefly, a 
stock solution of β-hematin was prepared by dissolving 0.10 mg (0.15 μmol) β-hematin in 1 
mL of 0.4 M sodium hydroxide. The latter was diluted ten times in 0.4 M sodium hydroxide to 
generate a second stock solution. Individually, 0.7 mL of each stock solution was aliquoted into 
two different cell culture glass tubes. To each test tube, 0.62 mL of ultrapure water was added. 
The recrystallization of β-hematin was initiated by the addition of 0.68 mL of acetic acid. The 
final pH of the solution was 2.9. To observe the influence of CQ in the crystallization kinetics, 
the same procedure as for the crystallization of isolated heme was employed, but pure acetic 
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acid was substituted by a solution of 20.60 mg mL-1 (64.41 μmol mL-1) of CQ. The final CQ 
concentration in the crystallization reactions was 0.66 mg mL-1 (2.08 μmol mL-1). 
The UV-Vis measurement was performed on an Analytik Jena Specord 50 Plus 
spectrophotometer, using a disposable semi-micro poly(methyl methacrylate) cuvette (path 
length: 1 cm). 
Transmission electron microscopy (TEM) images were obtained using a FEI Tecnai 
Spirit at 120 kV. The images were recorded at a resolution of 2048x2048 pixels (Veleta CCD 
camera, Olympus). In the case of the imaging of hemozoin yielded from the crystallization 
reactions, the same conditions as in the DDLS experiments were employed. Then, the reaction 
volume was filtered with a syringe filter, and the filtrate was extensively washed with ultrapure 
water. Then, the crystals were retrieved by smearing the filter with 1 mL of ultrapure water. 5 
μl of the β-hematin suspensions were drop-casted onto a carbon-film square mesh copper grid 
(Electron Microscopy Sciences, CF-300-Cu) and the solvent was allowed to dry overnight. 
Fourier-transform infrared spectroscopy (FT-IR) spectra were collected by using a 
Perkin Elmer 65 spectrometer in attenuated total reflection (ATR) mode. 
X-ray diffraction (XRD) data was collected using a STOE STADI P diffractometer with 
a step size of 0.2 °(2θ) in transmission mode and a Cu target (λ = 1.5414 Å). The detector 
channels were calibrated by a Si standard. The x-axis is converted into q-space by the equation 
𝑞 = 4𝜋 𝜆⁄ 𝑠𝑖𝑛(𝜃), where 2𝜃 is the angle between the axes of the X-ray beam and detector, 
respectively, and 𝜆 the wavelength of the diffracted X-ray waves. 
To obtain a sufficient signal-to-noise ratio for the FT-IR and XRD experiments, 5 mg 
of hemozoin were dissolved in 1.32 mL of a 0.4 M NaOH aqueous solution, to which 1.24 mL 
of ultrapure water were added. The solution was stirred with a magnetic stirring bar. The 
crystallization process was initiated by the addition of 1.4 mL of acetic acid and the mixture 
was allowed to stir for a period of 2 h. The resulting crystals were isolated from the solution by 
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vacuum filtration over a polyvinylidene fluoride membrane filter (Duapore, pore size 0.45 μm). 
Then, the filtrate was washed thoroughly with dimethyl sulfoxide (DMSO) to remove non-
crystalized hematin. Finally, the filtrate was washed with ultrapure water to eliminate any 
remaining NaOH. Finally, the filtrate was then dried in a vacuum oven at 65 °C overnight. To 
isolate non-crystalline hematin, 5 mg of hemozoin were dissolved in 1.32 mL of 0.4 M NaOH 
aqueous solution. To eliminate the NaOH salts, the solution was passed through a silica gel 
plug with methanol as the mobile phase. Finally, the solvent was removed by rotary 
evaporation. 
Light scattering data were collected at constant temperature (21 °C) using a commercial 
goniometer instrument (3D LS Spectrometer, LS Instruments AG, Switzerland). The primary 
beam was formed by a linearly polarized and collimated laser beam (Cobolt 05-01 diode 
pumped solid state laser, λ = 660 nm, Pmax. = 500 mW), and the scattered light was collected by 
single-mode optical fibers equipped with integrated collimation optics. With respect to the 
primary beam, depolarized scattering was observed via cross-polarizers. The incoming laser 
beam passed through a Glan-Thompson polarizer with an extinction ratio of 10-6, and another 
Glan-Thompson polarizer, with an extinction ratio of 10-8, was mounted in front of the 
collection optics. The collected light was coupled into an avalanche photo diode detector 
(Perkin Elmer, Single Photon Counting Module) via laser-line filters. The photon counts were 
obtained at a sampling rate of 19 Hz. Each sample was ~0.05 s long, which also defined the 
lower limit of the available integration times. 
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